Healthtech Startups
17,194 companies tagged Healthtech, with their investors and founders.
0 investors
Lumedica Vision develops LumAI, software that uses AI to analyze retinal OCT imaging data and compares it against a database of known eye diseases to flag suspected pathology and support physician decision-making. The tool is designed for eye care providers to enable automated image classification at the point of care and expand screening for treatable retinal disease before vision loss.
0 investors
Lumina Pharmaceuticals is a clinical-stage company that develops diagnostic and therapeutic radiopharmaceuticals using peptide technology.
0 investors
0 investors
Lumitex designs and manufactures specialized lighting solutions for medical devices and industrial applications. The company provides engineering services, guidance on lighting technology selection, and in-house production to help customers integrate innovative lighting into their products.
0 investors
0 investors
0 investors
Lybrate is an online patient consulting portal that connects users with a network of over 150,000 doctors across medical specialties for online consultations and OPD appointment scheduling. It also coordinates elective surgical procedures through partner hospitals and clinics, serving patients across metro and Tier-2/Tier-3 cities in India.
0 investors
Lycia Therapeutics is a biotechnology company developing LYTAC (Lysosomal Targeting Chimera) therapeutics that bind disease-causing extracellular and cell-surface proteins and route them into the cell's lysosome for degradation. Its targeted protein degradation platform, based on research from Carolyn Bertozzi's lab at Stanford, aims to address proteins previously considered undruggable.
0 investors
0 investors
Lyssn provides AI-powered tools for behavioral health and child welfare organizations to reduce staff burnout and improve implementation of evidence-based practices.
0 investors
0 investors
Macrotope engineers protein antigens using its patented MacroAntigen/MAV platform, which tunes antigen conformational dynamics to broaden immune response for vaccine and therapeutic antibody discovery. It develops its own vaccine candidates (including for SARS-CoV-2 and related coronaviruses) and offers antibody discovery services to biopharma partners.
0 investors
0 investors
0 investors
Madison Vaccines Inc. (MVI) develops immunotherapies and therapeutic vaccines for prostate cancer, designed to be combined with standard-of-care treatments and checkpoint inhibitors across metastatic and non-metastatic stages. Its therapies target patients at all stages of prostate cancer to delay disease progression and enhance the effectiveness of PD-1 and AR axis inhibitors.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Magstim develops neurotechnology and neurostimulation devices for healthcare providers and researchers, focusing on neuromodulation and neurophysiology applications. The company manufactures and supports innovative medical devices used in patient care and neuroscience research globally.
0 investors
0 investors